BDO Wealth Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$90.5K Sell
745
-25
-3% -$3.33K 0.01% 354
2023
Q1
$118K Buy
770
+150
+24% +$24.7K 0.01% 309
2022
Q4
$111K Hold
620
0.01% 316
2022
Q3
$73K Sell
620
-22
-3% -$3.34K 0.01% 361
2022
Q2
$92K Sell
642
-285
-31% -$40.7K 0.01% 336
2022
Q1
$160K Sell
927
-93
-9% -$15.7K 0.02% 291
2021
Q4
$259K Buy
1,020
+12
+1% +$3.51K 0.03% 251
2021
Q3
$388K Buy
1,008
+33
+3% +$12.2K 0.04% 205
2021
Q2
$229K Sell
975
-50
-5% -$8.94K 0.03% 274
2021
Q1
$134K Buy
1,025
+315
+44% +$45.6K 0.02% 334
2020
Q4
$74K Buy
710
+10
+1% +$1.01K 0.01% 320
2020
Q3
$50K Buy
700
+200
+40% +$13.9K 0.01% 329
2020
Q2
$32K Buy
+500
New +$27.4K 0.01% 372

Other funds holding MRNA

BDO Wealth Advisors's MRNA Position: Q2 2023 in Review

BDO Wealth Advisors reduced its Moderna (MRNA) stake by 3.2% in Q2 2023, selling an estimated $3.33K and leaving 745 shares worth $90.5K. The position accounts for 0.01% of the portfolio, ranked #354.

BDO Wealth Advisors first reported a position in MRNA in Q2 2020 and has held it in 13 quarters since. The position peaked at $388K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • BDO Wealth Advisors held 745 shares of Moderna worth $90.5K as of Q2 2023.
  • BDO Wealth Advisors sold 25 Moderna shares in Q2 2023, an estimated $3.33K.
  • Moderna made up 0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #354 holding.
  • BDO Wealth Advisors first reported a position in Moderna in Q2 2020 and has held it in 13 quarters since.
  • BDO Wealth Advisors's Moderna position peaked at $388K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.